Share of Cost, Study Shows Promise For New Drug To Treat Fragile X

Saturday, May. 28th 2011 1:54 PM

The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in the larger follow-up clinical trial. The data from the early trial of 30 Fragile X patients, found the drug, called AFQ056, made by Novartis Pharmaceuticals, helped improve symptoms in some patients.

Posted on Saturday, May. 28th 2011 1:54 PM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply

You must be logged in to post a comment.